CATALYST PHARMACEUTICALS INC's ticker is CPRX and the CUSIP is 14888U101. A total of 87 filers reported holding CATALYST PHARMACEUTICALS INC in Q2 2015. The put-call ratio across all filers is 0.28 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2016 | $322,000 | -51.4% | 274,820 | +1.6% | 0.00% | -100.0% |
| Q4 2015 | $663,000 | -17.8% | 270,444 | +0.5% | 0.00% | 0.0% |
| Q3 2015 | $807,000 | -27.4% | 269,027 | -0.1% | 0.00% | 0.0% |
| Q2 2015 | $1,112,000 | +2038.5% | 269,221 | +2153.1% | 0.00% | – |
| Q1 2015 | $52,000 | +79.3% | 11,949 | +21.9% | 0.00% | – |
| Q4 2014 | $29,000 | -14.7% | 9,799 | -5.0% | 0.00% | – |
| Q3 2014 | $34,000 | +36.0% | 10,313 | +4.1% | 0.00% | – |
| Q2 2014 | $25,000 | – | 9,905 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 5,517,885 | $22,789,000 | 2.29% |
| March Altus Capital Management LP | 80,890 | $334,000 | 1.94% |
| TANAKA CAPITAL MANAGEMENT INC | 111,693 | $462,000 | 1.15% |
| PURA VIDA INVESTMENTS, LLC | 395,000 | $1,951,000 | 1.00% |
| Broadfin Capital, LLC | 4,183,177 | $17,277,000 | 0.93% |
| Catalyst Capital Advisors LLC | 1,310,000 | $5,411,000 | 0.63% |
| SPHERA FUNDS MANAGEMENT LTD. | 1,200,000 | $4,956,000 | 0.48% |
| Baker Brothers Advisors | 7,335,692 | $30,296,000 | 0.27% |
| TURNER INVESTMENTS LLC | 286,370 | $1,183,000 | 0.22% |
| Perceptive Advisors | 851,200 | $3,515,000 | 0.21% |